<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boutzoukas AE</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>BLRD VA</funding><funding>NIAID NIH HHS</funding><pagination>848-859</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11997972</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(4)</volume><pubmed_abstract>Carbapenem-resistant Enterobacterales (CRE) are an important threat to the health of solid organ transplant recipients (SOTr); data comparing outcomes of SOTr with CRE to non-SOTr with CRE are lacking. A matched cohort study was performed within 2 prospective, multicenter, cohort studies (Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacterales and Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacterales 2). The epidemiology, desirability of outcome rankings outcomes, and mortality of SOTr and non-SOTr hospitalized in the United States (December 2011-August 2017) with clinical isolates with Centers for Disease Control and Prevention-defined CRE were compared. In total, 121 SOTr and 242 matched non-SOTr were included. Fifty-one perce</pubmed_abstract><journal>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</journal><pubmed_title>Carbapenem-resistant Enterobacterales in solid organ transplant recipients.</pubmed_title><pmcid>PMC11997972</pmcid><funding_grant_id>I01 BX003741</funding_grant_id><funding_grant_id>R01 AI134637</funding_grant_id><funding_grant_id>P01 AI152999</funding_grant_id><funding_grant_id>UM1 AI104681</funding_grant_id><funding_grant_id>U19 AI144297</funding_grant_id><funding_grant_id>T32 AI141349</funding_grant_id><funding_grant_id>R01 AI150685</funding_grant_id><funding_grant_id>K24 AI121296</funding_grant_id><funding_grant_id>R01 AI148342</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Smitasin N</pubmed_authors><pubmed_authors>Cordova E</pubmed_authors><pubmed_authors>Su J</pubmed_authors><pubmed_authors>Di Castelnuovo V</pubmed_authors><pubmed_authors>Revolinski S</pubmed_authors><pubmed_authors>Hanson B</pubmed_authors><pubmed_authors>Herc E</pubmed_authors><pubmed_authors>Patel R</pubmed_authors><pubmed_authors>Tambyah PA</pubmed_authors><pubmed_authors>Patel G</pubmed_authors><pubmed_authors>Munita JM</pubmed_authors><pubmed_authors>Ostrowsky B</pubmed_authors><pubmed_authors>Fries BC</pubmed_authors><pubmed_authors>Sanchez ML</pubmed_authors><pubmed_authors>Doi Y</pubmed_authors><pubmed_authors>van Duin D</pubmed_authors><pubmed_authors>Fowler VG</pubmed_authors><pubmed_authors>Leroi M</pubmed_authors><pubmed_authors>Kerry</pubmed_authors><pubmed_authors>Eilertson B</pubmed_authors><pubmed_authors>Reyes J</pubmed_authors><pubmed_authors>Hu F</pubmed_authors><pubmed_authors>Gallagher JC</pubmed_authors><pubmed_authors>Figueroa J</pubmed_authors><pubmed_authors>Dhar S</pubmed_authors><pubmed_authors>Manca C</pubmed_authors><pubmed_authors>Anderson DJ</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Henderson A</pubmed_authors><pubmed_authors>Chambers HF</pubmed_authors><pubmed_authors>Kim A</pubmed_authors><pubmed_authors>Dinh AQ</pubmed_authors><pubmed_authors>Dai W</pubmed_authors><pubmed_authors>Huskins C</pubmed_authors><pubmed_authors>Desai S</pubmed_authors><pubmed_authors>Wong D</pubmed_authors><pubmed_authors>McCarty T</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors><pubmed_authors>Cross HR</pubmed_authors><pubmed_authors>Marshall SH</pubmed_authors><pubmed_authors>Zong Z</pubmed_authors><pubmed_authors>Panesso D</pubmed_authors><pubmed_authors>Schmidt-Malan S</pubmed_authors><pubmed_authors>Paterson DL</pubmed_authors><pubmed_authors>Garner OB</pubmed_authors><pubmed_authors>Onate Gutierrez JM</pubmed_authors><pubmed_authors>Francois Jeff Jabbour J</pubmed_authors><pubmed_authors>Stryjewski M</pubmed_authors><pubmed_authors>Antibacterial Resistance Leadership Group and the MDRO Network Investigators</pubmed_authors><pubmed_authors>Salata RA</pubmed_authors><pubmed_authors>Rydell K</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Ge L</pubmed_authors><pubmed_authors>Baum K</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Hill C</pubmed_authors><pubmed_authors>Rudin SD</pubmed_authors><pubmed_authors>Kaye KS</pubmed_authors><pubmed_authors>Lautenbach E</pubmed_authors><pubmed_authors>Evans S</pubmed_authors><pubmed_authors>Valderrama S</pubmed_authors><pubmed_authors>McCarty TP</pubmed_authors><pubmed_authors>Evans B</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Cober E</pubmed_authors><pubmed_authors>Alenazi T</pubmed_authors><pubmed_authors>Eiras D</pubmed_authors><pubmed_authors>Xie Q</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Han JH</pubmed_authors><pubmed_authors>Villegas Botero MV</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Diaz L</pubmed_authors><pubmed_authors>Kanj SS</pubmed_authors><pubmed_authors>Spencer M</pubmed_authors><pubmed_authors>Weston G</pubmed_authors><pubmed_authors>Arias CA</pubmed_authors><pubmed_authors>Lee Chew K</pubmed_authors><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Richter S</pubmed_authors><pubmed_authors>Grant M</pubmed_authors><pubmed_authors>Lok JJ</pubmed_authors><pubmed_authors>Jacob JT</pubmed_authors><pubmed_authors>Satlin MJ</pubmed_authors><pubmed_authors>Kreiswirth BN</pubmed_authors><pubmed_authors>Vichez S</pubmed_authors><pubmed_authors>Marimuthu K</pubmed_authors><pubmed_authors>Salcedo S</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Abbo LM</pubmed_authors><pubmed_authors>Peleg A</pubmed_authors><pubmed_authors>Komarow L</pubmed_authors><pubmed_authors>Perez F</pubmed_authors><pubmed_authors>Banerjee R</pubmed_authors><pubmed_authors>Kalayjian RC</pubmed_authors><pubmed_authors>Tran TT</pubmed_authors><pubmed_authors>Garcia-Diaz J</pubmed_authors><pubmed_authors>Boutzoukas AE</pubmed_authors><pubmed_authors>Bonomo RA</pubmed_authors><pubmed_authors>Arias R</pubmed_authors><pubmed_authors>Wortmann G</pubmed_authors><pubmed_authors>Waters M</pubmed_authors><pubmed_authors>Rioseco M</pubmed_authors><pubmed_authors>Farrell JJ</pubmed_authors><pubmed_authors>Ordonez K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Carbapenem-resistant Enterobacterales in solid organ transplant recipients.</name><description>Carbapenem-resistant Enterobacterales (CRE) are an important threat to the health of solid organ transplant recipients (SOTr); data comparing outcomes of SOTr with CRE to non-SOTr with CRE are lacking. A matched cohort study was performed within 2 prospective, multicenter, cohort studies (Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacterales and Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacterales 2). The epidemiology, desirability of outcome rankings outcomes, and mortality of SOTr and non-SOTr hospitalized in the United States (December 2011-August 2017) with clinical isolates with Centers for Disease Control and Prevention-defined CRE were compared. In total, 121 SOTr and 242 matched non-SOTr were included. Fifty-one perce</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-02T20:14:08.168Z</modification><creation>2025-07-10T03:08:22.636Z</creation></dates><accession>S-EPMC11997972</accession><cross_references><pubmed>39522694</pubmed><doi>10.1016/j.ajt.2024.10.020</doi></cross_references></HashMap>